New insights on long COVID
With around 5% of COVID-19 patients estimated to develop long COVID, it remains a global health issue. To help doctors and the community, experts have launched […]
World-first trial aims to boost vaccine responses in infants
A first of its kind human trial based in Adelaide will investigate whether infant immune response to vaccines can be improved by giving probiotics to babies […]
Limits to access emergency pill
The accessibility of first-line oral emergency contraceptives in Australian community pharmacies is problematic – with a national survey finding almost one-third reporting they do not stock […]
Protecting South Australian first responders
Research shows emergency service personnel are twice as likely to develop anxiety, depression, and PTSD but a new Flinders University support program is aiming to prevent […]
Role of gut microbes in cancer therapy
Medical researchers have confirmed the role of a complex community of gut organisms in the effectiveness of cancer treatments and reducing toxicity. The comprehensive review of […]
New clue to treat brain cancer
A new research study shows that cerebrospinal fluid reduces current treatment efficacy in brain cancer and identifies new therapeutic opportunities. Cerebrospinal fluid, the clear colourless liquid […]
AI to help hospital discharge
A major new $2.9 million digital health project led by Flinders University will target the dosage and failures of prescription drugs used by patients at home […]
Clues to the cause of chronic gut pain
New insights into chronic gut pain offer hope for improved treatments for irritable bowel syndrome and anxiety treatment. A research team led by Flinders University Professor […]
New COVID study gives key vaccine insights
A new study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system. The […]